Xiongfei Liao

Xiongfei Liao

Auto-generated profile, based on publicly available information

Xiongfei Liao

Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, Affiliated Cancer Hospital of University and Electronic Science and Technology of China, Chengdu, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2023 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
XFXi Feng
Xi Feng
BTBin Tang
Bin Tang
XYXinghong Yao
Xinghong Yao
Feixiang ZhaoFeixiang Zhao
Feixiang Zhao
XLXiongfei Liao
Xiongfei Liao
Lucia Clara OrlandiniLucia Clara Orlandini
Lucia Clara Orlandini
Background: Magnetic resonance-guided adaptive radiotherapy (MRgART) treatment sessions at MR-Linac are time-consuming and changes in organs at risk volumes can impact the treatment dosimetry. This study aims to evaluate the feasibility to control bladder filling during the rectum MRgART online session and its effectiveness on plan dosimetry. Methods: A total of 109 online adaptive sessions of 24 rectum cancer patients treated at Unity 1.5 T MR-Linac with a short course radiotherapy (25 Gy, 5 Gy × 5) for whom the adaptive plan was optimized and recalculated online based on the daily magnetic resonance imaging (MRI) were analysed. Patients were fitted with a bladder catheter to control bladder filling; the bladder is emptied and then partially filled with a known amount of saline at the beginning and end of the online session. A first MRI ( $${\mathrm{MRI}}_{\mathrm{i}}$$ MRI i ) acquired at the beginning of the session was used for plan adaptation and the second ( $${\mathrm{MRI}}_{\mathrm{f}}$$ MRI f ) was acquired while approving the adapted plan and rigidly registered with the first to ensure the appropriateness of the isodoses on the ongoing delivery treatment. For each fraction, the time interval between the two MRIs and potential bladder changes were assessed with independent metrics, and the impact on the plan dosimetry was evaluated by comparing target and organs at risk dose volume histogram cut-off points of the plan adapted on $${\mathrm{MRI}}_{\mathrm{i}}$$ MRI i and recalculated on $${\mathrm{MRI}}_{\mathrm{f}}$$ MRI f . Results: Median bladder volume variations, DSC, and HD of 8.17%, 0.922, and 2.92 mm were registered within a median time of 38 min between $${\mathrm{MRI}}_{\mathrm{i}}$$ MRI i and $${\mathrm{MRI}}_{\mathrm{f}}$$ MRI f ; dosimetric differences < 0.65% were registered for target coverage, and < 0.5% for bladder, small bowel and femoral heads constraints, with a p value > 0.05. Conclusion: The use of a bladder filling control procedure can help ensure the dosimetric accuracy of the online adapted treatment delivered.

14 December 2023 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
KYKe Yuan
Ke Yuan
XYXinghong Yao
Xinghong Yao
XLXiongfei Liao
Xiongfei Liao
PDPen Diao
Pen Diao
XXXin Xin
Xin Xin
Lucia Clara OrlandiniLucia Clara Orlandini
Lucia Clara Orlandini
Background: Breast cancer is the most widespread cancer in women and young women worldwide. Moving towards customised radiotherapy, balancing the use of the available technology with the best treatment modality may not be an easy task in the daily routine. This study aims to evaluate the effectiveness of introducing IQ-feasibility into clinical practice to support the decision of free-breathing (FB) versus breath-hold (BH) left-sided breast irradiations, in order to optimise the technology available and the effectiveness of the treatment. Methods: Thirty-five patients who received 3D radiotherapy treatment of the left breast in deep-inspiration BH were included in this retrospective study. Computed tomography scans in FB and BH were acquired for each patient; targets contoured in both imaging datasets by an experienced radiation oncologist, and organs at risk delineated using automatic segmentation software were exported to PlanIQ™ (Sun Nuclear Corp.) to generate feasibility dose volume histogram (FDVHs). The dosimetric parameter of BH versus FB FDVH, and BH clinical dataset versus BH FDVH were compared. Results: A total of 30 patients out of 35 patients analysed, presented for the BH treatments a significant reduction (p < 0.05) in the heart mean dose ( $${{\text{D}}}_{{\text{m}}}$$ D m ), volume receiving 5 Gy ( $${{\text{V}}}_{5{\text{Gy}}}$$ V 5 Gy ) and 20 Gy ( $${{\text{V}}}_{20{\text{Gy}}}$$ V 20 Gy ), of 35.7%, 54.5%, and 2.1%, respectively; for the left lung, a lower reduction was registered and significant only for $${{\text{V}}}_{5{\text{Gy}}}$$ V 5 Gy (21.4%, p = 0.046). For the remaining five patients, the FDVH cut-off points of heart and lung were superimposable with differences of less than 1%. Heart and left lung dosimetric parameters of the BH clinical plans are located in the difficult zone of the FDVH and differ significantly (p < 0.05) from the corresponding parameters of the FDVH curves delimiting this buffer area between the impossible and feasible zones, respectively. Conclusion: The use of PlanIQTM as a decision-support tool for the FB versus BH treatment delivery modality allows customisation of the treatment technique using the most appropriate technology for each patient enabling accurate management of available technologies.

1 July 2025 in BMC Cancer
Verified
Journal Article
Open access
PDF file
MLMin Liu
Min Liu
FYFeng Yang
Feng Yang
BTBin Tang
Bin Tang
XXXin Xin
Xin Xin
XLXiongfei Liao
Xiongfei Liao
Lucia Clara OrlandiniLucia Clara Orlandini
Lucia Clara Orlandini
The MR-guided adaptive radiotherapy (MRgART) workflow at the 1.5 T Unity MR-Linac relies on synthetic CT (sCT) generated through bulk density assignment. Although sCT-based dose calculations are the standard approach, it is well known that their accuracy can be compromised in lung tumors due to the high dose gradients surrounding the targets. This study investigates clinical cases to determine whether these challenges affect all lung targets or if, for a subset partially located in high-density dose regions, the sCT calculations performed in the Unity clinical workflow are sufficiently accurate, supporting their routine clinical application. Forty-eight lung cancer patients undergoing stereotactic body radiotherapy at Unity MR-Linac, were included in this study. Patients were stratified into two groups based on target position: $$\:{\text{G}}_{\text{A}\text{T}\text{M}}$$ group including targets attached to thoracic wall or mediastinum, and $$\:{\text{G}}_{\text{I}\text{P}\text{T}}$$ (group isolated pulmonary target), including targets entirely within the lung parenchyma and surrounded by air-filled lung tissue. The reference treatment plans ( $$\:{\text{T}\text{P}}_{\text{R}\text{E}\text{F}}$$ ) were optimised on the simulation CT using inverse-planning intensity modulated radiation therapy (IMRT) with the Monaco treatment planning system to deliver 50 Gy in 5 fractions. $$\:{\text{T}\text{P}}_{\text{R}\text{E}\text{F}}$$ included all contour information needed to generate the sCT through bulk electron density assignment, the standard procedure for Unity MR-Linac. To evaluate the dosimetric accuracy of sCT-based dose calculations, a second plan ( $$\:{\text{T}\text{P}}_{\text{s}\text{C}\text{T}}$$ ) was created by recalculating $$\:{\text{T}\text{P}}_{\text{R}\text{E}\text{F}}$$ on the sCT derived from the reference CT. The sCT was generated using the MRgART routine, which assigns mean ED values to all contoured structures. Dose-volume histograms were compared between $$\:{\text{T}\text{P}}_{\text{R}\text{E}\text{F}}$$ and $$\:{\text{T}\text{P}}_{\text{s}\text{C}\text{T}}$$ for targets and organs at risk (OARs), with additional evaluation of tumor control probability, and normal tissue complication probability. Dose distributions were further evaluated using global gamma analysis with 3%/3 mm and 2%/2 mm criteria. Significant differences (p < 0.05) in key dosimetric parameters ( $$\:{\text{V}}_{50\text{G}\text{y}}$$ , $$\:{\text{V}}_{45\text{G}\text{y}}$$ , $$\:{\text{D}}_{50\text{\%}}$$ ) were observed between $$\:{\text{T}\text{P}}_{\text{R}\text{E}\text{F}}$$ and $$\:{\text{T}\text{P}}_{\text{s}\text{C}\text{T}}$$ in the $$\:{\text{G}}_{\text{I}\text{P}\text{T}}$$ group, with percentage differences reaching up to 3.49%. Conversely, in $$\:{\text{G}}_{\text{A}\text{T}\text{M}}$$ , percentage differences were less than 1% and not statistically significant (p > 0.05). For OARs, no significant differences (p > 0.05) were observed in either group, except for the lungs minus the gross tumor volume (lungs-GTV), where percentage differences remained below 1.5%. Radiobiological modelling yielded consistent results, confirming the dosimetric findings. Gamma analysis showed consistent dose distributions, with a global pass rate above 95% for 3%/3 mm criteria and above 90% for 2%/2 mm criteria. This study demonstrates that sCT-based dose calculations are feasible and reliable for pulmonary targets attached to the thoracic wall or mediastinum, supporting their routine integration into MRgART workflows on the Unity MR-Linac. However, for isolated pulmonary targets, deviations should be considered when implementing sCT-based planning in clinical practice.